| Tag | Content |
|---|
EnhancerAtlas ID | HS105-12682 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr11:6639010-6640000 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | | Pou2f3 | MA0627.1 | chr11:6639370-6639386 | TCAAATTTGCATACTT | - | 6.53 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09637 | chr11:6620372-6642742 | CD14 | | SE_56702 | chr11:6636693-6641303 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CAGGGATTCA GAAGAGGCAC TTGCCCTCAT TCATTGCTTT CCCAAACTCC CCCTTTTGGA 60
CCTCAACTAT GAGACATCAG GACTTCCCAA AGCCTGGAAC AGGGTAAAGG AGGGCTATGT 120
GTGCAGGTGT AGGGTGTACT TGGGAAGCAG AGGAAGAAAA GGCTGGAGAG ACTTGAAATG 180
CCATGGCCAA TAATATGGAT TTACCCTAAA GGCCAGTAAG TTGCAAATGT CGCACCACAG 240
CATGTATTGC CATGATCATG AAAATGAATG AGGTTAATAC ATATAAATTT TCCATTTTAA 300
TTTTAAGCTT ATGTCCGGTA AATGTTTTCA AATCTTTCGG TACCAGTTAT TCAGTTTAGC 360
TCAAATTTGC ATACTTGTTG ATTTTAAGCT TAACACGATG GTGAGTCACT GTTTCCTGCC 420
ATGCACACTA GTGTCACACT GCCCCGTCCC CAGCCTCTGC AGTTCACAAG CACACACTCC 480
CCCTGCTGTG AAGGGCTTTA ACCAGGAGAA GGAACCAATC CATTTTGACT GTTGGAGAGA 540
CTGTTTTGAA GCAGAGTGGG GGAGTACAGT GAGGGGTGGG GTGGAGGGAG GAGACTGCAG 600
ATCAGCTGGG GAGCTGGGCA GTAGTCCAGG AGTGGGAATA AATAACGGAG TTGGTCGTAA 660
CAAAAGACGG CAAGAAGGAG ATTAATCCAA AGGCTCTTTG GGAGTTAGAA CTGGCAGCCT 720
TAGTATGTGA ACAAAAGAGG AAATTAGAAT GGATTTGAGG GTAGGGGAAG GAACGTAAGT 780
TGTACTAGAT GCCTGGTAGC TAGTAAGTAG CAGAGTCAGA ATTTGAGTTC GTATTTGATC 840
ATAAAGCCTG TATACTGAAC CACATCCCCT TTTAGGTTTC TAGCCTGAGG AACACAAGTG 900
TCTTGGCAGG CTCTGACATG ATCGCCATCC CATGCCCAAC CCAGCCCTGT GTCCCTCCAC 960
CGCATCCCAC ATCCTGTCCT CAGTCCCAAA 990
|
